- Home
- OPK vs ARQT Comparison
OPK vs ARQT Comparison
Compare OPK & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPK
- ARQT
- Stock Information
- Founded
- OPK 2007
- ARQT 2016
- Country
- OPK United States
- ARQT United States
- Employees
- OPK N/A
- ARQT N/A
- Industry
- OPK Biotechnology: Pharmaceutical Preparations
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- OPK Health Care
- ARQT Health Care
- Exchange
- OPK Nasdaq
- ARQT Nasdaq
- Market Cap
- OPK 989.0M
- ARQT 1.1B
- IPO Year
- OPK 1995
- ARQT 2020
- Fundamental
- Price
- OPK $1.50
- ARQT $13.83
- Analyst Decision
- OPK Strong Buy
- ARQT Strong Buy
- Analyst Count
- OPK 3
- ARQT 5
- Target Price
- OPK $2.75
- ARQT $17.00
- AVG Volume (30 Days)
- OPK 2.5M
- ARQT 1.8M
- Earning Date
- OPK 02-25-2025
- ARQT 02-25-2025
- Dividend Yield
- OPK N/A
- ARQT N/A
- EPS Growth
- OPK N/A
- ARQT N/A
- EPS
- OPK N/A
- ARQT N/A
- Revenue
- OPK $711,408,000.00
- ARQT $138,708,000.00
- Revenue This Year
- OPK N/A
- ARQT $215.24
- Revenue Next Year
- OPK $0.00
- ARQT $53.63
- P/E Ratio
- OPK N/A
- ARQT N/A
- Revenue Growth
- OPK N/A
- ARQT 182.84
- 52 Week Low
- OPK $0.86
- ARQT $4.44
- 52 Week High
- OPK $1.76
- ARQT $16.20
- Technical
- Relative Strength Index (RSI)
- OPK 45.83
- ARQT 52.81
- Support Level
- OPK $1.46
- ARQT $12.61
- Resistance Level
- OPK $1.50
- ARQT $14.29
- Average True Range (ATR)
- OPK 0.05
- ARQT 0.95
- MACD
- OPK 0.00
- ARQT -0.18
- Stochastic Oscillator
- OPK 37.50
- ARQT 37.88
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.